invIOs presents positive patient data from ongoing Phase 1b
Poster presentation shows treatment with APN401, an autologous cell therapy product targeting the master immune checkpoint Cbl-b, resulted in stabilization...
Source: globenewswire.com
Page 12 - Solid Tumor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Solid Tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Solid Tumor Today - Breaking & Trending Today
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Discovery collaboration underway with Center for Cellular Immunotherapies Lab at University of Pennsylvania to Study Combinations of Novel Viral Immunotherapy and CAR-T Cell Therapy Candidates in Solid
Source: finanznachrichten.de
Fighting against cancer with innovative immune checkpoint therapy
Cancers often bypass antitumor immunity by affecting immune checkpoint expression, as such, immune checkpoint inhibition therapy is emerging as an attractive treatment in the battle against cancer.
Source: news-medical.net
Histone Deacetylase 2 (Transcriptional Regulator Homolog
Summary Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3. 5. ...
Source: globenewswire.com
Adaptimmune Therapeutics PLC: Adaptimmune Reports Positive Data in its SURPASS Trial; Outlines Plans for Advanced Clinical Development in Multiple MAGE-A4 Positive Solid Tumors
- 44% Objective Response Rate (ORR) with a single dose of ADP-A2M4CD8 in 25 heavily pre-treated patients with late-stage ovarian, urothelial, and head & neck cancers -- Further clinical development planned
Source: finanznachrichten.de